Arpita Ghosh Mitra*

Associate Laboratory Director, Jeenomics Transplant Laboratory and NCGM, India

*Corresponding Author: Arpita Ghosh Mitra, Associate Laboratory Director, Jeenomics Transplant Laboratory and NCGM, India.

Received: February 27, 2023; Published: May 01, 2023

Abstract

Cornea is an immune privileged site and an immune privileged tissue which provides protection from the Immune-Mediated destruction. Human Corneal Transplantation (Keratoplasty) is considered to have superior short and long term outcomes and minimal requirement for immunosuppression compared to Solid Organ Transplants because of the inherent immune privilege and tolerogenic mechanisms associated with the anterior segment of the eye.

References

Citation

Citation: Arpita Ghosh Mitra. “Corneal Transplantation: Immunobiology and Immune-Mediated Allograft Rejection".Acta Scientific Ophthalmology 6.6 (2023): 01-02.

Copyright

Copyright: © 2023 Arpita Ghosh Mitra. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.